ArticleBMC cardiovascular disorders2026
Psychosocial burden of cardiac patients: a retrospective in-patient analysis.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac patients face a higher risk of developing depression or anxiety, displaying a bidirectional risk-relationship. While previous studies have focused on specific cardiac subgroups, such as heart failure (HF) populations, our study investigates a broad cardiac population to explore cofactors most strongly correlating with depressive or anxious symptoms.
methodsA total of n = 511 patients (mean age 63.57 ± 15.86 years, 41.9% female, 58.1% male) with heterogenous admission diagnoses admitted to the “Siebeck” ward of the Centre of Internal Medicine at the University Hospital Heidelberg were retrospectively analyzed. Psychiatric symptoms were quantified using the Patient Health Questionnaire-9-item depression module (PHQ-9), the 7-item Generalized Anxiety Disorder scale (GAD-7) and the Short Form-36 (SF-36) to evaluate health-related quality of life (HRQoL). Regression analyses included the variables sex, age, HF (mild, moderate and severe), the presence of an implanted cardioverter defibrillator (ICD), former or current cardiac decompensation (CD), cardiomyopathy (CM), and diabetes mellitus (DM) as predictors. A p < 0.05 was considered statistically significant.
resultsYounger age (PHQ-9: β = -0.117, p = 0.012; GAD-7: β = -0.205, p < 0.001) and female sex (PHQ-9: β = 0.118, p = 0.01; GAD-7: β = 0.164, p < 0.001) were significantly associated with elevated PHQ-9 and GAD-7 scores. CD (β = 0.149, p = 0.001), an ICD (β = 0.15, p = 0.002), and comorbid DM (β = 0.095, p = 0.036) were significantly associated with higher depression scores, while an ICD additionally correlated with more anxiety (β = 0.112, p = 0.024). Lower physical HRQoL was present in patients with DM (β = -0.163, p = 0.001) and CD (β = -0.147, p = 0.004). Relatively low adjusted R² values in the regression models reflect that only a small proportion of the variance in PHQ-9 (R² = 0.094) and GAD-7 (R² = 0.079) can be explained. Although severe HF was associated with higher PHQ-9 scores, the multivariate regression analyses did not confirm a significant association.
conclusionsDepressive and anxious symptoms, as well as physical HRQoL, are more strongly linked to specific clinical characteristics than to HF severity itself. Instead, younger age, female sex, CD, an ICD, and comorbid DM showed stronger associations with significantly increased depressive symptoms and lower HRQoL, while those with an ICD additionally described higher levels of anxiety. These findings support targeted psychosocial screening in these high-risk cardiac subgroups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.